Pfizer’s Covid-19 vaccine doesn’t add a ‘tremendous amount’ to the company’s valuation: Analyst

Navin Jacob – UBS Pharmaceuticals Analyst joins Yahoo Finance’s On The Move panel to deep dive into the latest pharmaceutical earnings reports.
…read more

Source:: Yahoo Finance

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.